A Cognitive Strategy for Stopping Smoking: The Five-Day Plan

  • R. Romand


Cigarette cessation affects a wide range of psychological functions. Deprivation is characterized by several psychological and clinical problems that are mainly present during the first week of tobacco deprivation. Smoking cessation produces several symptoms such as: anxiety, inadequate sleep, irritability, difficulty in concentrating, hunger, headaches etc… Most of these symptoms are related to the decrease of nicotine levels in the nervous systems, i.e. the mesolimbic dopamine system (Koob and Bloom, 1988; Schulteis and Koob, 1994). Although recent medical strategies offer a fairly good rate of success (Fiore et al., 1994) for smoking cessation, other older strategies based on cognitive processes offer a good alternative to those who do not want to use drugs to stop smoking. One very effective strategy used in Europe for more than 20 years is the Five Day Plan which copes with the multiple components of tobacco dependence. The components of tobacco dependence have been well summarized by Fiore et al. (1992) and are as follow:
  • Habit-related smoking: several automatic habits are related to motor activity and need to be modified by cognitive strategies

  • Pleasure: smoking increases pleasure: about 25% of relapses occur when smokers are happy

  • Negative feelings: smoking reduces negative feelings: about 65% of relapses occur when former smokers are anxious or sad


Smoking Cessation Group Therapy Cognitive Strategy Nicotine Patch Abstinence Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Koob F and Bloom FE. Cellular and molecular mechanisms of drug dependence. Science, 1988; 242: 715–723.PubMedCrossRefGoogle Scholar
  2. 2.
    Dark side of drug dependence. Nature, 1994; 371: 108–109.CrossRefGoogle Scholar
  3. 3.
    Fiore MC, Smith SS, Jorenby DE and Baker TB. The effectiveness of the nicotine patch for smoking cessation. Journal of the American Medical Association, 1994; 271: 19–47.CrossRefGoogle Scholar
  4. 4.
    Fiore MC, Jorenby DE, Baker TM and Kendord SL. Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. Journal of American Medical Association, 1992; 268: 2687–2694.CrossRefGoogle Scholar
  5. 5.
    Schwartz JL. Review and evaluation of smoking cessation methods: United States and Canada, 1978–1985. US Department of Health and Human Services, Public Health Service, National Institutes of Health Publication, 1987; 87–2940.Google Scholar
  6. 6.
    Fagertröm KO, Säwe U and Tonnesen P. Therapeutic use of nicotine patches: Efficacy and safety. Journal of Drugs Development, 1993; 5: 191–205.Google Scholar
  7. 7.
    Hurt RD, Dale LC, Fredrickson PA, Caldwell CC, Lee GA, Offord KP, Lauger GG, Marusic Z, Neese LW and Lundberg TG. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. Journal of the American Medical Association, 1994; 271: 595–600.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • R. Romand
    • 1
  1. 1.Ligue Vie et SantéLe Mée sur SeineFrance

Personalised recommendations